British Pharmacological Society members are invited to contribute to the Society’s response to consultations.
Consultation responses are approved by the Rapid Response Policy Group (RRPG), which comprises the President, President-Elect, another Trustee and Vice President - Policy and Public Engagement (all elected by the membership). The RRPG will consider all consultation responses to reach a consensus position before submission.
01 Aug 2016
NHS England published a discussion paper presenting proposals which have been developed working with a range of stakeholders, on the establishment of the four Regional Medicines Optimisation Committees (RMOCS) across England. The purpose of the paper is to test the proposals through a number of open questions. Please refer to this link to find the discussion paper. The deadline for submissions is Monday 19 September 2016. Please send your comments to firstname.lastname@example.org.
22 Jul 2016
The European Medicines Agency has launched a consultation on a concept paper that outlines changes to current guidance on first-in-human clinical trials. The changes to the guidance were proposed by the European Medicines Agency (EMA), in cooperation with the European Commission and the Member States of the European Union to further improve strategies to identify and mitigate risks to trial participants. The release of the concept paper is part of a review of the EMA guideline published in 2007 that provides advice on first-in-human clinical trials, in particular on the data needed to enable their appropriate design and allow the initiation of treatment in trial participants.
Link to the concept paper on the revision of the 'Guideline on strategies to identify and mitigate risks for first-in-human clinical trials with investigational medicinal products'
Guideline on strategies to identify and mitigate risks for first-in-human clinical trials with investigational medicinal productsThe deadline for submissions is Friday 30 September 2016. Please send your comments to email@example.com.